These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23294227)

  • 21. Consonant Acoustics in Parkinson's Disease and Multiple Sclerosis: Comparison of Clear and Loud Speaking Conditions.
    Tjaden K; Martel-Sauvageau V
    Am J Speech Lang Pathol; 2017 Jun; 26(2S):569-582. PubMed ID: 28654940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linguistic complexity, speech production, and comprehension in Parkinson's disease: behavioral and physiological indices.
    Walsh B; Smith A
    J Speech Lang Hear Res; 2011 Jun; 54(3):787-802. PubMed ID: 21060141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Internally Versus Externally Cued Speech in Parkinson's Disease and Cerebellar Disease.
    Weir-Mayta P; Spencer KA; Eadie TL; Yorkston K; Savaglio S; Woollcott C
    Am J Speech Lang Pathol; 2017 Jun; 26(2S):583-595. PubMed ID: 28654941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profiling Speech and Pausing in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).
    Yunusova Y; Graham NL; Shellikeri S; Phuong K; Kulkarni M; Rochon E; Tang-Wai DF; Chow TW; Black SE; Zinman LH; Green JR
    PLoS One; 2016; 11(1):e0147573. PubMed ID: 26789001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parametric quantitative acoustic analysis of conversation produced by speakers with dysarthria and healthy speakers.
    Rosen KM; Kent RD; Delaney AL; Duffy JR
    J Speech Lang Hear Res; 2006 Apr; 49(2):395-411. PubMed ID: 16671852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Articulation time does not affect speeded cognitive performance in multiple sclerosis.
    Roberg BL; Somogie M; Thelen JM; Bruce JM
    Cogn Behav Neurol; 2015 Mar; 28(1):33-8. PubMed ID: 25812129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phonetic variation in dysarthric speech as a function of sampling task.
    Brown A; Docherty GJ
    Eur J Disord Commun; 1995; 30(1):17-35. PubMed ID: 7647390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally Detectable Change of Speech Intelligibility in Speakers With Multiple Sclerosis and Parkinson's Disease.
    Stipancic KL; Tjaden K
    J Speech Lang Hear Res; 2022 May; 65(5):1858-1866. PubMed ID: 35442761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in speech production associated with alphabet supplementation.
    Hustad KC; Lee J
    J Speech Lang Hear Res; 2008 Dec; 51(6):1438-50. PubMed ID: 18664687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson's disease and multiple sclerosis.
    Tjaden K; Sussman JE; Wilding GE
    J Speech Lang Hear Res; 2014 Jun; 57(3):779-92. PubMed ID: 24687042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What speech can tell us: A systematic review of dysarthria characteristics in Multiple Sclerosis.
    Noffs G; Perera T; Kolbe SC; Shanahan CJ; Boonstra FMC; Evans A; Butzkueven H; van der Walt A; Vogel AP
    Autoimmun Rev; 2018 Dec; 17(12):1202-1209. PubMed ID: 30316992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged response times characterize cognitive performance in multiple sclerosis.
    Achiron A; Doniger GM; Harel Y; Appleboim-Gavish N; Lavie M; Simon ES
    Eur J Neurol; 2007 Oct; 14(10):1102-8. PubMed ID: 17880565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of concurrent motor, linguistic, or cognitive tasks on speech motor performance.
    Dromey C; Benson A
    J Speech Lang Hear Res; 2003 Oct; 46(5):1234-46. PubMed ID: 14575355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Articulatory Kinematic Characteristics Across the Dysarthria Severity Spectrum in Individuals With Amyotrophic Lateral Sclerosis.
    Lee J; Bell M; Simmons Z
    Am J Speech Lang Pathol; 2018 Feb; 27(1):258-269. PubMed ID: 29209698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expiratory muscle strength training: speech production outcomes in patients with multiple sclerosis.
    Chiara T; Martin D; Sapienza C
    Neurorehabil Neural Repair; 2007; 21(3):239-49. PubMed ID: 17351085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acoustic and perceptual correlates of faster-than-habitual speech produced by speakers with Parkinson's disease and multiple sclerosis.
    Kuo C; Tjaden K; Sussman JE
    J Commun Disord; 2014; 52():156-69. PubMed ID: 25287378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inducing speech errors in dysarthria using tongue twisters.
    Kember H; Connaghan K; Patel R
    Int J Lang Commun Disord; 2017 Jul; 52(4):469-478. PubMed ID: 27891744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examining the effects of multiple sclerosis on speech production: does phonetic structure matter?
    Rosen KM; Goozée JV; Murdoch BE
    J Commun Disord; 2008; 41(1):49-69. PubMed ID: 17509609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.